Russell Investments Group’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Buy
3,471
+2,337
+206% +$137K ﹤0.01% 2939
2026
Q1
$43.3K Sell
1,134
-150
-12% -$4.75K ﹤0.01% 3370
2025
Q4
$28K Sell
1,284
-874
-41% -$18.1K ﹤0.01% 3506
2025
Q3
$46.3K Sell
2,158
-3,602
-63% -$80.8K ﹤0.01% 3318
2025
Q2
$148K Buy
5,760
+637
+12% +$18.6K ﹤0.01% 2727
2025
Q1
$188K Buy
5,123
+3,326
+185% +$114K ﹤0.01% 2615
2024
Q4
$55.1K Buy
1,797
+1,097
+157% +$36.5K ﹤0.01% 2798
2024
Q3
$26.4K Buy
700
+179
+34% +$6.9K ﹤0.01% 2903
2024
Q2
$20.6K Sell
521
-40
-7% -$1.29K ﹤0.01% 2934
2024
Q1
$18.9K Hold
561
﹤0.01% 2775
2023
Q4
$18.7K Sell
561
-199
-26% -$6.42K ﹤0.01% 2752
2023
Q3
$23.8K Buy
760
+626
+467% +$19.7K ﹤0.01% 2863
2023
Q2
$4.25K Buy
134
+125
+1,389% +$4.04K ﹤0.01% 3140
2023
Q1
$297 Buy
+9
New +$295 ﹤0.01% 3236
2020
Q4
Sell
-22,235
Closed -$727K 3035
2020
Q3
$727K Buy
+22,235
New +$941K ﹤0.01% 2214

Other funds holding ATEX

Russell Investments Group's ATEX Position: Q2 2026 in Review

Russell Investments Group increased its Anterix (ATEX) stake by 206% in Q2 2026, buying an estimated $137K and bringing the position to 3,471 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #2939.

Russell Investments Group first reported a position in ATEX in Q3 2020 and has held it in 15 quarters since. The position peaked at $727K in Q3 2020. 65 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Russell Investments Group held 3,471 shares of Anterix worth $357K as of Q2 2026.
  • Russell Investments Group bought 2,337 Anterix shares in Q2 2026, an estimated $137K.
  • Anterix made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2939 holding.
  • Russell Investments Group first reported a position in Anterix in Q3 2020 and has held it in 15 quarters since.
  • Russell Investments Group's Anterix position peaked at $727K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.